In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Immunotherapeutic advances have dramatically changed the treatment landscape for a host of different cancer types. Notably, immune checkpoint inhibitors...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
As 2019 draws to a close, the American Association for Cancer Research (AACR) is grateful for our growing ranks...
Each month, the editors from the portfolio of scientific journals published by the American Association for Cancer Research (AACR)...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
November is National Family Caregivers Month—a time to raise awareness for the approximately 3 million people in the U.S....
Lung cancer – one of the most commonly diagnosed cancers in the United States – is an area of...
Earlier this year, the American Association of Cancer Research (AACR) partnered with Novocure, a global oncology company, to launch...
The Centers for Medicare & Medicaid Services offers value-based programs that “reward health care providers with incentive payments for...
There has been an explosion in the number of cancer therapeutics and clinical trials in the recent past, owing...